Pharmanutra S.p.A.
PHN.MI · MIL
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €523 | €545 | €603 | €730 |
| - Cash | €16 | €19 | €22 | €29 |
| + Debt | €24 | €28 | €18 | €6 |
| Enterprise Value | €531 | €554 | €598 | €707 |
| Revenue | €116 | €101 | €83 | €68 |
| % Growth | 15% | 21.2% | 22.4% | – |
| Gross Profit | €83 | €49 | €30 | €32 |
| % Margin | 71.3% | 48.4% | 36.2% | 47.2% |
| EBITDA | €32 | €27 | €25 | €20 |
| % Margin | 27.6% | 26.3% | 29.5% | 29.1% |
| Net Income | €17 | €13 | €15 | €14 |
| % Margin | 14.3% | 12.7% | 18% | 20.2% |
| EPS Diluted | 1.73 | 1.33 | 1.56 | 1.42 |
| % Growth | 30.1% | -14.7% | 9.9% | – |
| Operating Cash Flow | €21 | €12 | €14 | €20 |
| Capital Expenditures | -€4 | -€13 | -€23 | -€5 |
| Free Cash Flow | €16 | -€1 | -€9 | €15 |